Survival analyses revealed a significantly increased OS of patients with serous ovarian cancers expressing no or low levels of ERRβ compared to those with serous tumors showing higher ERRβ expression (chi-squared statistic of the log-rank, p = 0.038). Here, ESRRB is linked to ovarian serous adenocarcinoma.